Ligufalimab (Anti-CD47)

Ligufalimab (Anti-CD47) is a humanized immunoglobulin G4 (IgG4) monoclonal antibody targeting leukocyte surface antigen CD47, with potential immune checkpoint inhibitory and antineoplastic activities. MW : 144.58 KD.

• Supplier: Selleck Chemicals
• Product #: A2825
• Sku #: A2825-1mg